|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-2-28
|
|
pubmed:abstractText |
Uncontrolled studies have reported encouraging outcomes for patients with high-risk primary breast cancer treated with high-dose chemotherapy and autologous hematopoietic stem cell support. We conducted a prospective randomized trial to compare standard-dose chemotherapy with the same therapy followed by high-dose chemotherapy. PATIENTS and
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
pubmed-author:AmesF CFC,
pubmed-author:AnderssonBB,
pubmed-author:BooserD JDJ,
pubmed-author:BuzdarA UAU,
pubmed-author:ChamplinR ERE,
pubmed-author:DeisserothA BAB,
pubmed-author:DykeP CPC,
pubmed-author:GajewskiJ LJL,
pubmed-author:GiraltSS,
pubmed-author:HolmesF AFA,
pubmed-author:HortobagyiG NGN,
pubmed-author:KhouriII,
pubmed-author:McNeeseM DMD,
pubmed-author:RondonGG,
pubmed-author:SingletaryS ESE,
pubmed-author:SmithT LTL,
pubmed-author:SneigeNN,
pubmed-author:StromE AEA,
pubmed-author:TheriaultR LRL,
pubmed-author:ValeroVV
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
2
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
225-33
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10655439-Adult,
pubmed-meshheading:10655439-Aged,
pubmed-meshheading:10655439-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10655439-Breast Neoplasms,
pubmed-meshheading:10655439-Chemotherapy, Adjuvant,
pubmed-meshheading:10655439-Cyclophosphamide,
pubmed-meshheading:10655439-Disease-Free Survival,
pubmed-meshheading:10655439-Doxorubicin,
pubmed-meshheading:10655439-Drug Administration Schedule,
pubmed-meshheading:10655439-Female,
pubmed-meshheading:10655439-Fluorouracil,
pubmed-meshheading:10655439-Follow-Up Studies,
pubmed-meshheading:10655439-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10655439-Humans,
pubmed-meshheading:10655439-Lymphatic Metastasis,
pubmed-meshheading:10655439-Middle Aged,
pubmed-meshheading:10655439-Neoadjuvant Therapy,
pubmed-meshheading:10655439-Prospective Studies,
pubmed-meshheading:10655439-Radiotherapy, Adjuvant,
pubmed-meshheading:10655439-Survival Analysis,
pubmed-meshheading:10655439-Transplantation, Autologous,
pubmed-meshheading:10655439-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
|
|
pubmed:affiliation |
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. ghortoba@notes.mdacc.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
